Wallbox NV

Wallbox operates with a negative equity position of EUR -31.69 million and a debt-to-equity ratio of -6.24, indicating a highly leveraged capital structure. The company holds EUR 1.61 million in cash and equivalents, but its current ratio of 0.57 suggests liquidity constraints. The negative net income of EUR -101.76 million and operating loss of EUR -99.29 million highlight significant financial stress. Profitability metrics show a return on equity of 3.21% and a negative return on assets of -0.42%, both underperforming the industry median for Electrical Components & Equipment. Gross profit of EUR 55.54 million represents 38.3% of revenue, but this is insufficient to offset operating expenses. The company's EBITDA multiple of -2.47 and EV-to-revenue ratio of 1.69 suggest a challenging valuation profile. Revenue is concentrated in three regions: Europe, Asia, and the Americas, with no disclosed segment breakdown. The company's exposure to these regions may limit diversification benefits, particularly in light of geopolitical drivers such as the 2026-04 EU emissions regulations. No major customers or product lines are disclosed to indicate diversification within segments. The company's revenue of EUR 145.12 million in the latest period reflects a growth trajectory that is not yet disclosed in terms of year-over-year change. Analysts have set a mean price target of EUR 5.00, implying a 73.6% upside from the current market price of EUR 2.88. However, the company's free cash flow of EUR -79.04 million and capital expenditure of EUR -10.04 million suggest ongoing investment and operational challenges. Risk factors include a negative net cash position and a high debt load, which could lead to liquidity stress. The risk assessment indicates a medium liquidity risk and low dilution risk, but the company's negative equity and operating cash flow raise concerns about solvency. No recent dilutive events are disclosed, but the company's capital structure may require further equity issuance. Recent filings and transcripts indicate ongoing efforts to expand product offerings and secure regulatory approvals. The company has not disclosed any material recent events that would significantly alter its strategic direction or financial outlook. Analysts have issued one "Buy" and one "Hold" recommendation, with no "Strong Buy" ratings, reflecting cautious sentiment.